Literature DB >> 3877952

Recalled life expectancy information, phase of illness and hope in cancer patients.

M H Stoner, S H Keampfer.   

Abstract

In this study two research questions were addressed: What is the relationship between recalled life expectancy information and hope in cancer patients? What effect does phase of illness have on the level of hope in cancer patients? A scale to measure hope was developed, used, and evaluated. In 55 cancer patients, an analysis of variance showed a significant main effect on hope for recalled life expectancy; difference in level of hope was found in cancer patients at different phases of illness. The findings indicated that individuals having no recollection of receiving information regarding their prognosis were more hopeful. The results have implications for determining what, how much, when, and how to communicate life expectancy information to patients who have cancer or other life-threatening illnesses.

Entities:  

Mesh:

Year:  1985        PMID: 3877952     DOI: 10.1002/nur.4770080309

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  4 in total

1.  Giving me hope: women's reflections on a breastfeeding peer support service.

Authors:  Gill Thomson; Nicola Crossland; Fiona Dykes
Journal:  Matern Child Nutr       Date:  2011-11-28       Impact factor: 3.092

2.  Hope and mood changes throughout the primary brain tumor illness trajectory.

Authors:  Alvina A Acquaye; Lin Lin; Elizabeth Vera-Bolanos; Mark R Gilbert; Terri S Armstrong
Journal:  Neuro Oncol       Date:  2015-06-23       Impact factor: 12.300

3.  Level and direction of hope in cancer patients: an exploratory longitudinal study.

Authors:  Michael Sanatani; Gil Schreier; Larry Stitt
Journal:  Support Care Cancer       Date:  2007-09-20       Impact factor: 3.603

4.  Expressive Arts Therapy Combined with Progressive Muscle Relaxation following Music for Perioperative Patients with Gynecological Malignancies: A Pilot Study.

Authors:  Xing Liu; Jian-Hua Ren; Sha-Sha Jiang; Yan Tan; Se-Ge Ma; Yan Huang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.